Hepatotoxicity of antituberculosis drugs.
作者信息
Ormerod L P, Skinner C, Wales J
出版信息
Thorax. 1996 Feb;51(2):111-3. doi: 10.1136/thx.51.2.111.
Abstract
摘要
相似文献
1
Hepatotoxicity of antituberculosis drugs.抗结核药物的肝毒性
Thorax. 1996 Feb;51(2):111-3. doi: 10.1136/thx.51.2.111.
2
Hepatotoxicity of antituberculosis drugs.抗结核药物的肝毒性
Thorax. 1996 Nov;51(11):1168-9. doi: 10.1136/thx.51.11.1168-d.
3
Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.抗结核药物所致肝毒性的发生率及危险因素评估
Ann Pharmacother. 2004 Jun;38(6):1074-9. doi: 10.1345/aph.1D525. Epub 2004 Apr 30.
4
Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.埃塞俄比亚南部达罗地区结核病患者中抗结核药物所致肝毒性的发生率及相关危险因素：一项队列研究
Int J Mycobacteriol. 2016 Mar;5(1):14-20. doi: 10.1016/j.ijmyco.2015.10.002. Epub 2015 Oct 30.
5
Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.在坦桑尼亚住院的肺结核患者中，抗结核药物性肝毒性并不常见。
Trop Med Int Health. 2010 Feb;15(2):268-72. doi: 10.1111/j.1365-3156.2009.02449.x.
6
Evaluation of patient-related factors associated with causality, preventability, predictability and severity of hepatotoxicity during antituberculosis [correction of antituberclosis] treatment.抗结核治疗期间与肝毒性的因果关系、可预防性、可预测性和严重程度相关的患者因素评估。 （注：原文中“antituberclosis”拼写错误，应为“antituberculosis”）
Pharmacol Res. 2005 Apr;51(4):353-8. doi: 10.1016/j.phrs.2004.10.009.
7
A prospective survey of drug induced hepatotoxicity in a large hospital.一家大型医院药物性肝毒性的前瞻性调查。
Indian J Gastroenterol. 1992 Jan;11(1):13-5.
8
[Association of P450-2E1 and GSTM1 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity].[细胞色素P450-2E1和谷胱甘肽S-转移酶M1基因多态性与抗结核药物性肝损伤易感性的关系]
Zhonghua Jie He He Hu Xi Za Zhi. 2009 Aug;32(8):585-7.
9
[The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].N-乙酰转移酶2基因多态性与肺结核患者抗结核药物性肝损伤的相关性
Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Jan;45(1):36-40.
10
[Hepatotoxicity caused by antituberculosis drugs in pediatrics].
Rev Gastroenterol Peru. 2005 Oct-Dec;25(4):362-5.
引用本文的文献
1
Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury.肝功能异常识别时间对预测抗结核药物性肝损伤风险的研究
J Clin Transl Hepatol. 2023 Apr 28;11(2):425-432. doi: 10.14218/JCTH.2022.00077. Epub 2022 May 20.
2
The Genetics of Ethambutol-Induced Optic Neuropathy: A Narrative Review.乙胺丁醇所致视神经病变的遗传学：一项叙述性综述。
Neuroophthalmology. 2022 Aug 2;46(5):304-313. doi: 10.1080/01658107.2022.2100916. eCollection 2022.
3
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.药物性肝损伤：亚太肝病学会研究共识指南。
Hepatol Int. 2021 Apr;15(2):258-282. doi: 10.1007/s12072-021-10144-3. Epub 2021 Feb 27.
4
Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.利福平在人类结核病中的临床药代动力学和药效学。
Clin Pharmacokinet. 2019 Sep;58(9):1103-1129. doi: 10.1007/s40262-019-00764-2.
5
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.REMOxTB 研究中与结核病化疗相关的肝毒性。
BMC Med. 2018 Mar 28;16(1):46. doi: 10.1186/s12916-018-1033-7.
6
Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.抗结核治疗引起的药物性肝损伤：来自英国一个大型结核病中心的回顾性研究。
BMC Infect Dis. 2017 Mar 24;17(1):231. doi: 10.1186/s12879-017-2330-z.
7
Early monitoring for detection of antituberculous drug-induced hepatotoxicity.早期监测以检测抗结核药物引起的肝毒性。
Korean J Intern Med. 2016 Jan;31(1):65-72. doi: 10.3904/kjim.2016.31.1.65. Epub 2015 Dec 28.
8
Non-adherence and drug-related interruptions are risk factors for delays in completion of treatment for tuberculosis.不遵医行为和与药物相关的中断是结核病治疗完成延迟的危险因素。
Int J Tuberc Lung Dis. 2013 Apr;17(4):486-92. doi: 10.5588/ijtld.12.0133. Epub 2013 Feb 7.
9
Severe hepatic complications of antituberculous therapy.抗结核治疗的严重肝脏并发症。
Can J Infect Dis. 1999 Mar;10(2):167-9. doi: 10.1155/1999/342613.
10
Hepatotoxic effects of therapies for tuberculosis.结核病治疗的肝毒性作用。
Nat Rev Gastroenterol Hepatol. 2010 Oct;7(10):543-56. doi: 10.1038/nrgastro.2010.134. Epub 2010 Aug 31.
本文引用的文献
1
Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis.
Tuber Lung Dis. 1994 Feb;75(1):58-60. doi: 10.1016/0962-8479(94)90104-X.
2
Anti-tuberculous therapy and acute liver failure.
Lancet. 1995 Mar 4;345(8949):555-6. doi: 10.1016/s0140-6736(95)90468-9.
3
Hepatotoxicity caused by the combined action of isoniazid and rifampicin.异烟肼和利福平联合作用引起的肝毒性。
Thorax. 1995 Feb;50(2):213-4. doi: 10.1136/thx.50.2.213.
4
Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales.在英格兰和威尔士新确诊的肺结核患者中发生的死亡情况。
Br J Dis Chest. 1984 Apr;78(2):149-58.
5
Adverse effects of antituberculosis drugs.抗结核药物的不良反应。
Drugs. 1982 Jan-Feb;23(1-2):56-74. doi: 10.2165/00003495-198223010-00003.
6
7
Effect of rifampicin and isoniazid on liver function.利福平与异烟肼对肝功能的影响。
Br Med J. 1972 Jan 15;1(5793):148-50. doi: 10.1136/bmj.1.5793.148.
8
Ocular toxicity from ethambutol.乙胺丁醇引起的眼部毒性。
Thorax. 1986 Oct;41(10):737-9. doi: 10.1136/thx.41.10.737.
9
Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis.结核病复发、药物治疗方案与治疗依从性之间的相互关系。
Respir Med. 1991 May;85(3):239-42. doi: 10.1016/s0954-6111(06)80087-9.
10
Fatal hepatotoxicity of anti-tubercular chemotherapy.抗结核化疗的致命肝毒性
Lancet. 1991 Oct 26;338(8774):1083-4. doi: 10.1016/0140-6736(91)91943-o.
Zotero 插件